Tenthwave raises $6.5M seed for low-cost ultrasound-guided focused ultrasound tremor device
Summary
Pittsburgh-based Tenthwave secured $6.5M seed from UPMC Enterprises, Innovation Works, and Draper Triangle. The company is developing a focused ultrasound tremor treatment device guided by real-time ultrasound imaging rather than MRI, targeting a system cost of under $200,000 versus the $2M+ required for MRI-guided FUS. Targets outpatient clinic deployment.
Why it matters
Making focused ultrasound accessible at $200K per system versus $2M would open FUS tremor treatment to thousands of outpatient neurology clinics globally instead of being limited to academic medical centers with MRI suites. UPMC's participation gives Tenthwave premier clinical partner access from day one.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items โ updated daily.
Start free trial